165 related articles for article (PubMed ID: 37577144)
1. L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes.
Schlichtner S; Yasinska IM; Klenova E; Abooali M; Lall GS; Berger SM; Ruggiero S; Cholewa D; Milošević M; Gibbs BF; Fasler-Kan E; Sumbayev VV
Oncoimmunology; 2023; 12(1):2244330. PubMed ID: 37577144
[TBL] [Abstract][Full Text] [Related]
2. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated.
Charehjoo A; Majidpoor J; Mortezaee K
Int Immunopharmacol; 2023 May; 118():110032. PubMed ID: 36933494
[TBL] [Abstract][Full Text] [Related]
5. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
8. The kynurenine pathway in brain tumor pathogenesis.
Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ
Cancer Res; 2012 Nov; 72(22):5649-57. PubMed ID: 23144293
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Inducible Factor 1α (HIF1α) Suppresses Virus Replication in Human Cytomegalovirus Infection by Limiting Kynurenine Synthesis.
Wise LM; Xi Y; Purdy JG
mBio; 2021 Mar; 12(2):. PubMed ID: 33758082
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
Engin AB; Engin A
Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
[TBL] [Abstract][Full Text] [Related]
11. ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer.
Wu D; Wang G; Wen S; Liu X; He Q
Transl Oncol; 2024 Apr; 42():101900. PubMed ID: 38316094
[TBL] [Abstract][Full Text] [Related]
12. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
Bhutia YD; Babu E; Ganapathy V
Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
[TBL] [Abstract][Full Text] [Related]
14. The footprint of kynurenine pathway in every cancer: a new target for chemotherapy.
Ala M
Eur J Pharmacol; 2021 Apr; 896():173921. PubMed ID: 33529725
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
16. The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2.
Engin AB; Engin ED; Engin A
Environ Toxicol Pharmacol; 2021 Jan; 81():103520. PubMed ID: 33132153
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
18. Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.
Rad Pour S; Morikawa H; Kiani NA; Yang M; Azimi A; Shafi G; Shang M; Baumgartner R; Ketelhuth DFJ; Kamleh MA; Wheelock CE; Lundqvist A; Hansson J; Tegnér J
Sci Rep; 2019 Aug; 9(1):12150. PubMed ID: 31434983
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
Li Q; Harden JL; Anderson CD; Egilmez NK
J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
